Lokesh Sikaria Trust Dated 12/14/2012 - Net Worth and Insider Trading

Lokesh Sikaria Trust Dated 12/14/2012 Net Worth

The estimated net worth of Lokesh Sikaria Trust Dated 12/14/2012 is at least $313 dollars as of 2024-11-13. Lokesh Sikaria Trust Dated 12/14/2012 is the 10% Owner of Enveric Biosciences Inc and owns about 780 shares of Enveric Biosciences Inc (ENVB) stock worth over $313. Details can be seen in Lokesh Sikaria Trust Dated 12/14/2012's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lokesh Sikaria Trust Dated 12/14/2012 has not made any transactions after 2018-11-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Lokesh Sikaria Trust Dated 12/14/2012

Lokesh Sikaria Trust Dated 12/14/2012 Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lokesh Sikaria Trust Dated 12/14/2012 owns 1 companies in total, including Enveric Biosciences Inc (ENVB) .

Click here to see the complete history of Lokesh Sikaria Trust Dated 12/14/2012’s form 4 insider trades.

Insider Ownership Summary of Lokesh Sikaria Trust Dated 12/14/2012

Ticker	Comapny	Transaction Date	Type of Owner
ENVB	Enveric Biosciences Inc	2018-11-16	10 percent owner

Lokesh Sikaria Trust Dated 12/14/2012 Latest Holdings Summary

Lokesh Sikaria Trust Dated 12/14/2012 currently owns a total of 1 stock. Lokesh Sikaria Trust Dated 12/14/2012 owns 780 shares of Enveric Biosciences Inc (ENVB) as of November 16, 2018, with a value of $313.

Latest Holdings of Lokesh Sikaria Trust Dated 12/14/2012

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ENVB	Enveric Biosciences Inc	2018-11-16	780	0.40	313

Holding Weightings of Lokesh Sikaria Trust Dated 12/14/2012

Lokesh Sikaria Trust Dated 12/14/2012 Form 4 Trading Tracker

According to the SEC Form 4 filings, Lokesh Sikaria Trust Dated 12/14/2012 has made a total of 0 transactions in Enveric Biosciences Inc (ENVB) over the past 5 years. The most-recent trade in Enveric Biosciences Inc is the sale of 20 shares on November 16, 2018, which brought Lokesh Sikaria Trust Dated 12/14/2012 around $30,000.

Insider Trading History of Lokesh Sikaria Trust Dated 12/14/2012

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lokesh Sikaria Trust Dated 12/14/2012 Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lokesh Sikaria Trust Dated 12/14/2012 Ownership Network

Ownership Network List of Lokesh Sikaria Trust Dated 12/14/2012

No Data

Ownership Network Relation of Lokesh Sikaria Trust Dated 12/14/2012

Lokesh Sikaria Trust Dated 12/14/2012 Owned Company Details

What does Enveric Biosciences Inc do?

Who are the key executives at Enveric Biosciences Inc?

Lokesh Sikaria Trust Dated 12/14/2012 is the 10 percent owner of Enveric Biosciences Inc. Other key executives at Enveric Biosciences Inc include Chief Financial Officer Kevin Michael Coveney , Chief Financial Officer Robert Iv Dickey , and Chief Scientific Officer Peter J. Facchini .

Enveric Biosciences Inc (ENVB) Insider Trades Summary

Over the past 18 months, Lokesh Sikaria Trust Dated 12/14/2012 made no insider transaction in Enveric Biosciences Inc (ENVB). Other recent insider transactions involving Enveric Biosciences Inc (ENVB) include a net purchase of 1,000 shares made by Frank Pasqualone ,

In summary, during the past 3 months, insiders sold 0 shares of Enveric Biosciences Inc (ENVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enveric Biosciences Inc (ENVB) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Enveric Biosciences Inc (ENVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enveric Biosciences Inc Insider Transactions

No Available Data

Lokesh Sikaria Trust Dated 12/14/2012 Mailing Address

Above is the net worth, insider trading, and ownership report for Lokesh Sikaria Trust Dated 12/14/2012. You might contact Lokesh Sikaria Trust Dated 12/14/2012 via mailing address: 1659 Manasco Circle, Folsom Ca 95630.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.